Home Applications 204958 Application 204958
Type NDA
Sponsor CHIESI Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 KENGREAL CANGRELOR POWDER;INTRAVENOUS 50MG/VIAL Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N204958-001 KENGREAL CANGRELOR 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2015-06-22
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N204958-001 AP
Orange Book patents# Current patent rows page 1 of 1 · 7 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N204958-001 9925265 2029-05-13 U-2260 2018-04-11 N204958-001 9427448 2030-11-10 U-1926 2016-12-09 N204958-001 8680052 2033-03-09 U-2979 2015-07-16 N204958-001 10039780 2035-07-10 U-2260 2018-08-30 N204958-001 9295687 2035-07-10 Drug product 2016-03-29 N204958-001 9439921 2035-07-10 Drug product 2016-12-09 N204958-001 9700575 2035-07-10 Drug product 2017-07-28
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2015-06-22 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2015-06-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2015-06-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N204958-001 KENGREAL 50MG/VIAL POWDER / INTRAVENOUS RLD, RS 2015-06-22 e64feba35796…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2026-08-18 06:07:40 2026-07 N204958-001 AP 1 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N204958-001 AP 1 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204958-001 AP 1 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N204958-001 AP 1 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 9 · 322 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N204958-001 9925265 2029-05-13 U-2260 2018-04-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204958-001 9427448 2030-11-10 U-1926 2016-12-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204958-001 8680052 2033-03-09 U-2979 2015-07-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204958-001 10039780 2035-07-10 U-2260 2018-08-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204958-001 9295687 2035-07-10 Drug product 2016-03-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204958-001 9439921 2035-07-10 Drug product 2016-12-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204958-001 9700575 2035-07-10 Drug product 2017-07-28 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N204958-001 9925265 2029-05-13 U-2260 2018-04-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204958-001 9427448 2030-11-10 U-1926 2016-12-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204958-001 8680052 2033-03-09 U-2979 2015-07-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204958-001 10039780 2035-07-10 U-2260 2018-08-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204958-001 9295687 2035-07-10 Drug product 2016-03-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204958-001 9439921 2035-07-10 Drug product 2016-12-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204958-001 9700575 2035-07-10 Drug product 2017-07-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204958-001 9925265 2029-05-13 U-2260 2018-04-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204958-001 9427448 2030-11-10 U-1926 2016-12-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204958-001 8680052 2033-03-09 U-2979 2015-07-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204958-001 10039780 2035-07-10 U-2260 2018-08-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204958-001 9295687 2035-07-10 Drug product 2016-03-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204958-001 9439921 2035-07-10 Drug product 2016-12-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204958-001 9700575 2035-07-10 Drug product 2017-07-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N204958-001 9925265 2029-05-13 U-2260 2018-04-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204958-001 9427448 2030-11-10 U-1926 2016-12-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204958-001 8680052 2033-03-09 U-2979 2015-07-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204958-001 10039780 2035-07-10 U-2260 2018-08-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204958-001 9295687 2035-07-10 Drug product 2016-03-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204958-001 9439921 2035-07-10 Drug product 2016-12-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204958-001 9700575 2035-07-10 Drug product 2017-07-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204958-001 9925265 2029-05-13 U-2260 2018-04-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204958-001 9427448 2030-11-10 U-1926 2016-12-09 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204958-001 8680052 2033-03-09 U-2979 2015-07-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204958-001 10039780 2035-07-10 U-2260 2018-08-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204958-001 9295687 2035-07-10 Drug product 2016-03-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204958-001 9439921 2035-07-10 Drug product 2016-12-09 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204958-001 9700575 2035-07-10 Drug product 2017-07-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204958-001 9925265 2029-05-13 U-2260 2018-04-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204958-001 9427448 2030-11-10 U-1926 2016-12-09 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204958-001 8680052 2033-03-09 U-2979 2015-07-16 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204958-001 10039780 2035-07-10 U-2260 2018-08-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204958-001 9295687 2035-07-10 Drug product 2016-03-29 b8a1b40f171c…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 5 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 10122-620 KENGREAL cangrelor Chiesi USA, Inc. NDA Current 10122-620 KENGREAL cangrelor Chiesi USA, Inc. NDA Current 10122-620 KENGREAL cangrelor Chiesi USA, Inc. NDA Current 10122-620 KENGREAL cangrelor Chiesi USA, Inc. NDA Current 65293-003 KENGREAL cangrelor The Medicines Company NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 73345 SUPPL 2023-01-31 73303 SUPPL 2023-01-27 60663 SUPPL 2019-10-24 60650 SUPPL 2019-10-24 24485 ORIG 2015-07-29 22970 ORIG 2015-07-29 60122 SUPPL 2015-06-22 40428 ORIG 2015-06-22 10410 ORIG 2015-06-22